• العربية
  • فارسی
BrandBrand
  • Iran Insight
  • Politics
  • Economy
  • Analysis
  • Special Report
  • Opinion
  • Podcast
  • Live TV
  • Iran Insight
  • Politics
  • Economy
  • Analysis
  • Special Report
  • Opinion
  • Podcast
  • Live TV
  • Theme
  • Language
    • العربية
    • فارسی
  • Iran Insight
  • Politics
  • Economy
  • Analysis
  • Special Report
  • Opinion
  • Podcast
  • Live TV
All rights reserved for Volant Media UK Limited
volant media logo

Iran drug stocks under two months, 800 medicines at risk as FX delays bite

Dec 14, 2025, 08:35 GMT+0Updated: 22:46 GMT+0

Iran’s medicine and infant-formula stocks average less than two months, with as many as 800 drug lines at risk of shortage within three months, industry representatives said, citing four-to-five-month delays in foreign-exchange allocation.

Babak Mesbahi, a presidium member of the Iranian Pharmacists Association, said sanctions are indirectly choking payment channels and logistics.

“Based on recent officials’ statements, the country’s medicine reserves on average are less than two months,” he said. “Infant formula faces a similar situation, and about 800 items will face shortages over the next three months.”

Mesbahi told Didban Iran that “Sanctions do not directly target medicine and infant formula, but their side effects are entirely palpable. Currency transfers have become difficult and allocation faces problems, and these issues are directly caused by sanctions.”

Asked whether the government has eased FX transfers, Mesbahi said: “As far as I know, nothing specific has been done. Right now there are pro forma invoices that have remained four to five months in the allocation and transfer queue,” he added.

The end of preferential exchange rates on many imported inputs has accelerated price rises for finished medicines and raw materials, according to pharmacists’ associations.

Hadi Ahmadi, a board member of the Iranian Pharmacists Association, said daily currency volatility and rising input costs are pushing up prices, even for common medicines.

“About 70% of production costs – packaging, auxiliaries and other inputs – follow the free-market exchange rate, and only roughly 30% relates to active ingredients, so price increases are unavoidable,” Ahmadi told ILNA.

“When prices rise and insurance does not keep pace, patients either take incomplete regimens or walk away, and the treatment path is disrupted.”

He added that only two to three million doses of influenza vaccine were imported versus a need of six to seven million for a population near 90 million, and distribution was late, which contributed to wider spread of flu.

Most Viewed

Iran is running out of economic escape routes
1

Iran is running out of economic escape routes

2
ANALYSIS

US strikes on Iran now serve the blockade

3

US says it can sustain Iran blockade for ‘foreseeable future’

4
ANALYSIS

Once US blockaded Iran, China’s ‘Malaysian’ oil imports dried up

5
ANALYSIS

Istanbul meeting: A new division of labor in the Iran war?

Banner
Banner
Banner
Banner
Banner

Spotlight

  • Baluch insurgency tests the limits of a war-weakened Islamic Republic
    PODCAST

    Baluch insurgency tests the limits of a war-weakened Islamic Republic

  • US strikes on Iran now serve the blockade
    ANALYSIS

    US strikes on Iran now serve the blockade

  • Salvation or tragedy? Iranians debate prospect of another war

    Salvation or tragedy? Iranians debate prospect of another war

  • More patrols, slower internet suggest Tehran is bracing for trouble
    VOICES FROM IRAN

    More patrols, slower internet suggest Tehran is bracing for trouble

  • Iran’s evasion network survives, but the crude feeding it has run dry

    Iran’s evasion network survives, but the crude feeding it has run dry

  • Once US blockaded Iran, China’s ‘Malaysian’ oil imports dried up
    ANALYSIS

    Once US blockaded Iran, China’s ‘Malaysian’ oil imports dried up

  • Istanbul meeting: A new division of labor in the Iran war?
    ANALYSIS

    Istanbul meeting: A new division of labor in the Iran war?

  • China values Iran but won't pay any price to defend it
    ONE-ON-ONE

    China values Iran but won't pay any price to defend it

  • Iran medical suppliers warn of worsening drug shortages

    Iran medical suppliers warn of worsening drug shortages